Clinical Leader - Helping clinical research professionals connect and collaborate

cyber security sign-GettyImages-1070773010

Unlocking AI Value For Clinical Research Associates

Clinical research associates (CRAs) have largely been late to adopt AI. CRAs who adopt it can streamline repetitive work while also freeing capacity for high-judgment work.

GUEST COLUMNISTS

Participant Payment — Make It Make Cents
Participant payment practices and expectations vary wildly. With advocate T.J. Sharpe, explore why sponsors need to rethink how they appreciate participants' time, effort, and burden.
What Ecological Momentary Assessment Taught Us About Real-World Hearing Outcomes
Ecological momentary assessment (EMA) reveals how people experience hearing challenges beyond the clinic. Here, researchers highlight its relevance in designing real-world hearing studies.
Calidi's Study Aims To Have An Oncolytic Virus Outsmart The Immune System
Calidi’s Eric Poma, Ph.D., explains how CLD-401 could evade immune clearance — and how the biotech is designing Phase 1 to prove safety and efficacy fast.
New Imaging Approach Could Improve IPF Trial Design
AI-powered quantitative CT could help sponsors detect treatment effects earlier, strengthen IPF trial endpoints, and make better go/no-go decisions.
Most Patients Learn About A Trial Online, But Is That What They Want?
Patients want to hear about clinical trials from their doctors — but most learn out online. CISCRP explores how industry can change the referral pathway for better.
How Plain Language Summaries Created Under EU CTR Can Help Shape NIH Policy
As the NIH shapes its plain language summary policy, EU CTR experience offers practical lessons on clarity, privacy, consistency, and implementation.
Long-Distance Rare Disease Trials: Why PLL Landed On Australia And New Zealand
Australia and New Zealand had a lot to offer PLL Therapeutics, but speed and savings aren't the only upsides for running its rare disease trial from its European home.
Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?
Integrated technology platforms can connect R&D data, accelerate trials, strengthen quality, and cut costs — but successful adoption requires more than AI.

CLINICAL TRIAL WHITE PAPERS

Best Practices In Rare Disease Patient Recruitment
Recruiting for rare disease clinical trials is daunting, and making patients aware of clinical trials, involving them in trial design, and building trust are a few ways sponsors can boost recruitment.

How AI Is Reshaping Trial Design, Execution, And Disclosure
9/25/2025

AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.
How Sponsors Can Drive Success With Central eSource At Investigator Sites
6/17/2025

Centralized eSource systems enable complex clinical trials to align with key regulatory frameworks, including ICH E6(R3), ICH E8(R1), and 21 CFR 312, to meet the highest standards of GCP.
Five Preventable Clinical Design Pitfalls And How To Avoid Them
7/21/2026

While late-stage trial attrition is often attributed to inadequate safety or efficacy, the true failure may be insufficient upstream planning and/or misalignment between clinical and commercial goals.
Selecting A Central Lab Network For Radiopharmaceutical Readiness
9/29/2026

A wave of late-stage radiopharmaceutical trials is straining lab infrastructure concentrated in a handful of academic centers, limiting site diversity, expertise, and trial capacity nationwide.
Beyond The Benchmark: Innovative Trial Designs Transform Research
1/15/2026

Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.

More Clinical Trial White Papers

CLINICAL TRIAL APP NOTES & CASE STUDIES

Driving A High-Adherence LTFU Trial Without An EDC
10/29/2025

Discover how our partnership with a client was able to deliver a ten-year long-term follow-up (LTFU) trial that delivered an over 90% adherence rate while keeping trial costs low by not using an EDC.
Scaling Success: A Blueprint For Flexible Biometrics Partnerships
2/19/2026

Learn how a micro-FSP model and integrated biometrics team can scale from specialized support to a full-service solution, ensuring agility and consistency as clinical trial needs evolve.
Streamlining Pediatric Clinical Trials With Vestigo^®
5/8/2026

Utilizing a centralized, automated platform can eliminate the friction of manual accountability logs, ensuring audit readiness while providing real-time visibility into financial reporting.
Optimizing Clinical Supply Management With A One-Team Approach
7/15/2026

See how NewAmsterdam Pharma managed 11 global studies across 51 countries and 835 sites for 12,000+ patients without overwhelming their internal team.
Strategic Pre-IND Consulting For Gene Therapy In Rare Leukemia
4/11/2025

Learn about the collaborative efforts of an innovative biotech startup and Ergomed Consulting to overcome challenges in the pre-IND phase for a novel gene therapy targeting a rare form of leukemia.
Driving ROI: A Real-Time Clinical Trial Oversight Solution
8/3/2026

Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.

More Clinical Trial App Notes & Case Studies

NEWSLETTER ARCHIVE

More Newsletters

RECRUITMENT AND DIVERSITY

This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.

Can A Universal Health Screening Help Stop Clinical Trial Dropouts?

Could comprehensive health scans give trial participants meaningful value — and help sponsors reduce costly dropouts?
Participant Payment — Make It Make Cents

Participant payment practices and expectations vary wildly. With advocate T.J. Sharpe, explore why sponsors need to rethink how they appreciate participants' time, effort, and burden.
Most Patients Learn About A Trial Online, But Is That What They Want?

Patients want to hear about clinical trials from their doctors — but most learn out online. CISCRP explores how industry can change the referral pathway for better.

FOCUS ON PATIENTS

Can A Universal Health Screening Help Stop Clinical Trial Dropouts?

Could comprehensive health scans give trial participants meaningful value — and help sponsors reduce costly dropouts?
Participant Payment — Make It Make Cents

Participant payment practices and expectations vary wildly. With advocate T.J. Sharpe, explore why sponsors need to rethink how they appreciate participants' time, effort, and burden.
Most Patients Learn About A Trial Online, But Is That What They Want?

Patients want to hear about clinical trials from their doctors — but most learn out online. CISCRP explores how industry can change the referral pathway for better.